Back to search

CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients

Data up to Jan 2025

Published2009
Citations66
References38

Total Citations Per Year

Abstract

References (38)

Cancer Statistics, 2008

2008 • 10,165 citations

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

1992 • 3,099 citations

Mechanisms of Cancer Drug Resistance

2002 • 2,495 citations

National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000

2001 • 888 citations

DNA methylation in serum of breast cancer patients: an independent prognostic marker.

2003 • 319 citations

ABC-transporters: implications on drug resistance from microorganisms to human cancers

2003 • 294 citations

Transcriptional Regulation of the MDR1 Gene by Histone Acetyltransferase and Deacetylase Is Mediated by NF-Y

1998 • 289 citations

ATP binding cassette transporters and drug resistance in breast cancer.

2003 • 255 citations

Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients

2004 • 231 citations

Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs

2005 • 194 citations

Promoter Hypermethylation in Benign Breast Epithelium in Relation to Predicted Breast Cancer Risk

2005 • 186 citations

The Indian scene.

2001 • 183 citations

Evaluation of HER-2/neu Immunohistochemical Assay Sensitivity and Scoring on Formalin-Fixed and Paraffin-Processed Cell Lines and Breast Tumors

2002 • 177 citations

Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation

2002 • 173 citations

Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival

1990 • 171 citations

Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias

1998 • 166 citations

Transcriptional regulators of the human multidrug resistance 1 gene: recent views

2002 • 164 citations

Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India-A cross-sectional study

2005 • 147 citations

Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo

2009 • 145 citations

Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.

1997 • 141 citations

Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias

1998 • 133 citations

Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients

2007 • 111 citations

Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients

2007 • 100 citations

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

2005 • 83 citations

Prognostic relevance of P-glycoprotein expression in breast cancer

1995 • 81 citations

CpG Hypermethylation of MDR1 Gene Contributes to the Pathogenesis and Progression of Human Prostate Cancer

2004 • 79 citations

Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer-a prospective clinical study

2005 • 68 citations

Inhibitors of DNA methylation: beyond myelodysplastic syndromes

2005 • 67 citations

RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response

2004 • 63 citations

Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection

2002 • 61 citations

Predictive and prognostic markers for invasive breast cancer

2002 • 56 citations

Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy

2001 • 53 citations

Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.

2001 • 51 citations

Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results

2000 • 43 citations

Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer

2008 • 38 citations

5-aza-2'-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines

2005 • 29 citations

Silencing DNA Methyltransferase (DNMT) Enhances Glioma Chemosensitivity

2008 • 23 citations

Expression of MDR proteins in breast cancer and its correlation with some clinical and pathological parameters.

2006 • 18 citations

Cited By (0)

Loading...
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma… (2009) – Clinical Biochemistry | Metascience Observatory Explorer